Vidcast:  https://www.instagram.com/p/Cta2Lxot9ao/

The FDA has just approved Nalmefene, branded as Opvee, an opioid-antagonist with a 5 fold longer half life, 11 vs. 2 hours,  compared with the standard product naloxone.   This nasal spray, an Opiant 

Pharmaceutical product, will be available for use in children and adults 12 yrs and older.

https://jamanetwork.com/journals/jama/fullarticle/2805739

#opioids #naloxone #Nalmefene #Opvee #overdose